Sign up here to receive news updates via email.
-
January 20, 2026 |
Media, News and Updates, Press Releases
BPGbio Receives FDA Orphan Drug Designation for BPM31510 for the Treatment of Primary CoQ10 Deficiency
read more -
January 5, 2026 |
Media, News and Updates, News Archive
His Excellency Sheikh Dr. Khalid Bin Jabor Al Thani recognized among The 100 Most Influential People in Oncology in 2025
read more -
December 16, 2025 |
Media, News and Updates, Press Releases, Uncategorized
BPGbio Announces Publication of Pioneering Solid Tumor Study with BPM31510 IV using Patient Omics and Bayesian AI to Guide Clinical Development
read more -
November 19, 2025 |
Media, News and Updates, Press Releases
BPGbio to Present Translational and Trial-in-Progress Update in Glioblastoma at the 2025 Society for Neuro-Oncology (SNO) Annual Meeting
read more -
November 11, 2025 |
Media, News and Updates, Press Releases
BPGbio Appoints John Dvor as Executive Vice President, Corporate Development
read more -
November 6, 2025 |
Media, News and Updates, Press Releases
BPGbio Wins 2025 AI Drug Development Innovation Award from Biotech Breakthrough Awards
read more
